Evidence map›Paper›PMID 34624176›Full record

ArticleAndrology2022

Androgens and estrogens predict sexual function after autologous hematopoietic stem cell transplant in men.

Lindsey J Anderson, Dorota Migula, Rebecca Abay, Stephanie Crabtree, Solomon A Graf, Alvin M Matsumoto, Thomas R Chauncey, Jose M Garcia

Open access · greenAbstract read
In one paragraph

Article in Andrology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Lindsey J AndersonDepartment of Medicine, Division of Gerontology and Geriatric Medicine, University of Washington School of Medicine, Seattle, Washington, USA.ORCID 0000-0003-3810-2427
Dorota MigulaGeriatric Research, Education and Clinical Center, Veterans Affairs Puget Sound Health Care System, Seattle, Washington, USA.
Rebecca AbayGeriatric Research, Education and Clinical Center, Veterans Affairs Puget Sound Health Care System, Seattle, Washington, USA.
Stephanie CrabtreeBone Marrow Transplant Unit, Veterans Affairs Puget Sound Health Care System, Seattle, Washington, USA.
Solomon A GrafBone Marrow Transplant Unit, Veterans Affairs Puget Sound Health Care System, Seattle, Washington, USA.
Alvin M MatsumotoDepartment of Medicine, Division of Gerontology and Geriatric Medicine, University of Washington School of Medicine, Seattle, Washington, USA.
Thomas R ChaunceyBone Marrow Transplant Unit, Veterans Affairs Puget Sound Health Care System, Seattle, Washington, USA.
Jose M GarciaDepartment of Medicine, Division of Gerontology and Geriatric Medicine, University of Washington School of Medicine, Seattle, Washington, USA.
University of Puget Sound · USUniversity of Washington · USVA Puget Sound Health Care System · US

Funding

Vector and Transgenic Mouse CoreP30DK017047 · NIDDK · UNIVERSITY OF WASHINGTON · PI Karin E Bornfeldt · 1986 to 2026
$41.4M
PILOT STUDY--CLINICAL NUTRITION RESEARCHP30DK035816 · NIDDK · UNIVERSITY OF WASHINGTON · PI Ellen A Schur · 1986 to 2026
$30.4M
Diabetes, Obesity and Metabolism Training ProgramT32DK007247 · NIDDK · UNIVERSITY OF WASHINGTON · PI GREGORY J MORTON, KRISTINA Marie UTZSCHNEIDER · 1986 to 2026
$10.0M
Improving cancer-related fatigue, sexual dysfunction and quality of life in older men with cancer and androgen deficiencyR01AG061558 · NIA · SEATTLE INST FOR BIOMEDICAL/CLINICAL RES · PI BASARIA, SHEHZAD, DEL FABBRO, EGIDIO · 2019 to 2025
$3.4M
Improving Patient-Important Outcomes with Testosterone Replacement in Hypogonadal Men with a Prior History of CancerR01CA239208 · NCI · SEATTLE INST FOR BIOMEDICAL/CLINICAL RES · PI BASARIA, SHEHZAD, GARCIA, JOSE M. · 2019 to 2025
$3.3M
Neuromuscular electrical stimulation for physical function maintenance during hematopoietic stem cell transplantationIK2RX003245 · VA · VA PUGET SOUND HEALTHCARE SYSTEM · PI Lindsey Anderson · 2020 to 2026
–
The Role of Ghrelin and the GHSR-1a receptor in Sarcopenic ObesityI01BX002807 · VA · VA PUGET SOUND HEALTHCARE SYSTEM · PI GARCIA, JOSE M. · 2016 to 2025
–
BLRD VA I01 BX002807Congressionally Directed Medical Research Program CDMRP PC170059National Institute of Diabetes and Digestive and Kidney Diseases funded Nutrition Obesity Research Center DK035816National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases funded Nutrition Obesity Research Center DK035816NCI NIH HHS R01 CA239208NIA NIH HHS R01 AG061558NIDDK NIH HHS P30 DK017047NIDDK NIH HHS P30 DK035816NIDDK NIH HHS T32 DK007247NIH HHS R01AG061558NIH HHS R01CA239208RRD VA IK2 RX003245University of Washington T32 DK 007247-42Veterans Affairs BX002807Veterans Affairs : BX002807 : IK2 RX003245
6 · The paper itself

Abstract

backgroundAutologous hematopoietic stem cell transplantation (AHSCT) is associated with sexual dysfunction and hypogonadism. Androgens are associated with sexual function in healthy men, but the role of estrogens is less well-known, and the association of these sex steroids with sexual function during AHSCT has not been characterized.

objectivesThe purpose of this study was to determine the predictive value of sex hormones before and acutely after AHSCT on sexual function recovery. MATERIALS AND

methodsWe examined sex hormones and self-reported sexual function before (PRE) and 1-month post-AHSCT (MONTH1; n = 19), and sexual function again 1-year post-AHSCT in men (YEAR1; n = 15).

resultsSexual function decreased from PRE to MONTH1 (p ≤ 0.05) with no differences between PRE and YEAR1. Erectile dysfunction was prevalent at PRE (68.4%) and increased at MONTH1 (100%; p ≤ 0.05) but was not different between PRE and YEAR1 (60.0%). From PRE to MONTH1, total testosterone (TT), dihydrotestosterone (DHT), follicle-stimulating hormone, and sex-hormone-binding globulin (SHBG) increased (p ≤ 0.02) while estradiol (p ≤ 0.026) and estrone decreased (p ≤ 0.001). MONTH1 TT and DHT were associated with sexual function at MONTH1, while PRE SHBG, MONTH1 estradiol, and change in estrone predicted sexual function at YEAR1. DISCUSSION: Sexual dysfunction is very prevalent prior to AHSCT and is transiently and severely worsened acutely after. AHSCT induces acute decreases in total and free estrogens, with SHBG increases leading to increases in total androgens, without changes in free androgens.

conclusionAndrogens and estrogens are both adversely affected by AHSCT but may predict sexual dysfunction in this population. This supports the premise that estrogen impacts sexual function independent from androgens and that steroid hormones are associated with acute changes in sexual function in this setting. Larger, controlled trials with long-term sex hormone assessment will need to confirm the association between early changes in estrogens and long-term sexual function recovery.

Indexed as

AdolescentAdultAndrogensBiomarkersEstrogensHematopoietic Stem Cell TransplantationHumansLymphomaMaleMiddle AgedMultiple MyelomaPredictive Value of TestsSexual Dysfunction, PhysiologicalYoung AdultAndrogensBiomarkersEstrogenserectile dysfunctionestrogenhematopoietic stem cell transplantationsexual desiresexual functiontestosterone

Identifiers

PMID34624176
PMCPMC8760151
OpenAlexW3204723881

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.